Black Diamond Therapeutics (BDTX) EPS (2019 - 2026)
Black Diamond Therapeutics (BDTX) EPS from Dec 31, 2019 to Mar 31, 2026. The TTM Black Diamond Therapeutics (BDTX) EPS is -$0.76. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Black Diamond Therapeutics (BDTX) EPS CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | -31.70% |
| 5 Years TTM | -20.40% |
| All Time TTM | -15.82% |
Annual EPS change of Black Diamond Therapeutics (BDTX)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.16 | -140.30% |
| 2025 | $0.39 | -131.83% |
| 2024 | -$1.23 | -22.94% |
| 2023 | -$1.60 | -36.21% |
| 2022 | -$2.50 | -27.81% |
| 2021 | -$3.47 | +85.96% |
| 2020 | -$1.86 | +7.54% |
| 2019 | -$1.73 | +283.73% |
| 2018 | -$0.45 | N/A |
Comparison Black Diamond Therapeutics (BDTX) five years EPS CAGR with competitors
Black Diamond Therapeutics (BDTX) five years EPS CAGR is -20.40%.